Thieler Law Corp advises investors with losses exceeding $100,000 of the October 7, 2019 lead plaintiff deadline in a class action lawsuit filed against Evolent Health Inc (NYSE: EVH) (“Evolent” or “the Company”). The suit is pending in the U.S. District Court for the Eastern District of Virginia and investors, who purchased Evolent Health Inc securities between March 3, 2017 and May 28, 2019, have until October 7, 2019 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Evolent Health Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that Evolent's partnership model did not align the Company's interests with those of its partners, as the model was designed to inflate the Company's revenue by extracting enormous administrative and management fees at the expense of its operating partners such as Passport; Passport was struggling financially, particularly after Kentucky cut its reimbursement rates, and the partnership between Evolent and Passport was becoming increasingly unsustainable; Evolent was draining Passport of functions, employees and money, to such an extent that Passport was left on the verge of insolvency; Passport was conducting a bidding process for several months to sell itself to prevent liquidation; and as a result, Evolent’s public statements were materially false and misleading at all relevant times.

On May 29, 2019, the Company revealed that it had agreed to purchase a controlling interest in University Health Care, Inc., d/b/a/ Passport Health Plan, despite prior statements that acquiring health plans was not part of the Company’s strategic focus.

Following this news, NYSE: EVH fell $4.14 per share, nearly 30%, to close at $10.01 per share on May 29, 2019.

If you were negatively impacted by your investment in Evolent Health Inc securities between March 3, 2017 and May 28, 2019 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185